Prescription Drug Affordability Advisory Council elimination

Summary

The legislation repeals the Prescription Drug Affordability Advisory Council, updates conflict‑of‑interest and disclosure rules, and revises criteria for flagging high‑cost prescription drugs. It also appropriates $1.75 million in FY 2027 to the commissioner of commerce for health‑plan regulation and reduces the Department of Health’s FY 2027 budget by $1.75 million and $1.836 million. The changes impact council members, the Department of Health, the commissioner of commerce, health‑plan regulators, and Minnesota patients.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share